Anti-TNF antibodies, compositions, methods and uses
US7691378B2 · kind B2 · utility
23Cited by
17References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2004 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Nov 19, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for treating carcinomas or adenocarcinomas using at least one anti-TNF antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.